Isomorphic Labs offers Drug Design Engine
Product
Isomorphic Labs' Drug Design Engine builds on AlphaFold to predict biomolecular structures for drug discovery.
- Currently Offered
Isomorphic Labs' Drug Design Engine is an AI-first platform that builds on the Nobel-winning AlphaFold system to predict biomolecular structures and binding affinities with unprecedented accuracy.
The platform is used to advance drug discovery through a unified engine that integrates structural biology, chemistry, and machine learning to design novel therapeutics.
Isomorphic Labs' Drug Design Engine builds on AlphaFold to predict biomolecular structures for drug discovery.
Generate Platform is a generative biology platform that designs novel protein therapeutics.
AlphaFold is an AI system that predicts 3D protein structures from amino acid sequences, accelerating biological research and drug discovery.
LiveDesign is a collaborative design environment where discovery teams design, predict, and analyze small molecules together.
1910's ITO™ platform orchestrates multimodal AI and lab automation for small and large molecule drug discovery.
Biomedical AI platform that grounds biopharma R&D decisions in validated biology.
Atlas is a licensable protein-interaction data ecosystem from A-Alpha Bio for AI-enabled protein design.
Catalyst gives partner science teams direct platform access to Lila Iris and AI Science Factories.
Creation uses Lila Iris and AI Science Factories to generate validated scientific assets and company opportunities.
Biology-First AI platform predicts disease-matched compounds using multi-omics human data and functional validation.
GEMS (Genesis Exploration of Molecular Space) is a generative AI platform for small-molecule drug discovery.
Machine learning platform for drug discovery and development.
Generate Platform is a generative biology platform that designs novel protein therapeutics.
AlphaFold is an AI system that predicts 3D protein structures from amino acid sequences, accelerating biological research and drug discovery.
LiveDesign is a collaborative design environment where discovery teams design, predict, and analyze small molecules together.
1910's ITO™ platform orchestrates multimodal AI and lab automation for small and large molecule drug discovery.
Biomedical AI platform that grounds biopharma R&D decisions in validated biology.
Atlas is a licensable protein-interaction data ecosystem from A-Alpha Bio for AI-enabled protein design.
Makya is a generative AI platform that designs novel drug-like molecules for medicinal chemistry teams.
Catalyst gives partner science teams direct platform access to Lila Iris and AI Science Factories.
Creation uses Lila Iris and AI Science Factories to generate validated scientific assets and company opportunities.
Biology-First AI platform predicts disease-matched compounds using multi-omics human data and functional validation.
GEMS (Genesis Exploration of Molecular Space) is a generative AI platform for small-molecule drug discovery.
FutureHouse builds superintelligent AI agents for scientific discovery.
